Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
PUT
iShares MSCI Brazil ETF
EWZ
$8.92B
| $88.6M | 0.02% |
2,790,000
-1,485,000
| -35% | -$47M |
|
552
iShares MSCI South Korea ETF
EWY
$25.4B
| $88.6M | 0.02% |
910,980
+377,693
| +71% | +$34.5M |
|
553
Alnylam Pharmaceuticals
ALNY
$29.3B
| $88.5M | 0.02% |
222,561
+128,153
| +136% | +$56.7M |
|
554
Old Dominion Freight Line
ODFL
$44.6B
| $88.5M | 0.02% |
564,373
-37,564
| -6% | -$5.39M |
|
555
PUT
DoorDash
DASH
$91.9B
| $88.3M | 0.02% |
389,800
| – | – |
|
556
MongoDB
MDB
$33.3B
| $88.1M | 0.02% |
209,829
-5,726
| -3% | -$2.08M |
|
557
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| $87.9M | 0.02% |
1,607,209
-3,279,637
| -67% | -$178M |
|
558
CALL
Citigroup
C
$226B
| $87.8M | 0.02% |
752,500
-102,200
| -12% | -$10.6M |
|
559
PUT
D.R. Horton
DHI
$40.8B
| $86.6M | 0.02% |
601,000
+497,000
| +478% | +$75.7M |
|
560
ResMed
RMD
$31.5B
| $86.5M | 0.02% |
359,167
-220,465
| -38% | -$56.4M |
|
561
L3Harris
LHX
$54.4B
| $86.2M | 0.02% |
293,564
-146,417
| -33% | -$42.3M |
|
562
CALL
Super Micro Computer
SMCI
$21.1B
| $86.1M | 0.02% |
2,941,200
+1,566,900
| +114% | +$64.5M |
|
563
PUT
PayPal
PYPL
$50.1B
| $85.9M | 0.02% |
1,470,900
+256,700
| +21% | +$16.7M |
|
564
CALL
State Street Energy Select Sector SPDR ETF
XLE
$38.7B
| $85.8M | 0.02% |
1,920,000
-730,000
| -28% | -$32.5M |
|
565
PUT
Target
TGT
$68B
| $85.1M | 0.02% |
870,800
-356,500
| -29% | -$32.9M |
|
566
PUT
Burlington
BURL
$23.3B
| $84.8M | 0.02% |
293,500
-233,200
| -44% | -$63.3M |
|
567
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
| $84.3M | 0.02% |
3,616,734
+3,428,336
| +1,820% | +$71.6M |
|
568
State Street SPDR S&P Retail ETF
XRT
$652M
| $83.9M | 0.02% |
983,724
+73,159
| +8% | +$6.15M |
|
569
PUT
Vistra
VST
$48.7B
| $83.1M | 0.02% |
515,400
-292,000
| -36% | -$53.2M |
|
570
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $83.1M | 0.02% |
864,584
-236,354
| -21% | -$22.9M |
|
571
General Mills
GIS
$19.8B
| $83M | 0.02% |
1,785,989
+39,998
| +2% | +$1.9M |
|
572
CALL
Pfizer
PFE
$154B
| $82.8M | 0.02% |
3,325,100
+1,982,200
| +148% | +$50M |
|
|
573
CALL
PepsiCo
PEP
$188B
| $82.7M | 0.02% |
576,100
-100,200
| -15% | -$14.7M |
|
574
T. Rowe Price
TROW
$24.2B
| $82.4M | 0.02% |
805,062
+176,229
| +28% | +$18.2M |
|
575
Pultegroup
PHM
$24.5B
| $82.4M | 0.02% |
702,627
+39,249
| +6% | +$4.81M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.